Published in Can J Clin Pharmacol on January 23, 2006
Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry (2006) 2.49
Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. BMC Psychiatry (2011) 1.89
The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates. J Health Econ (2010) 1.30
Parent experiences questionnaire for outpatient child and adolescent mental health services (PEQ-CAMHS Outpatients): reliability and validity following a national survey. Child Adolesc Psychiatry Ment Health (2011) 1.02
Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis. Child Adolesc Psychiatry Ment Health (2011) 1.01
Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants. Eur Child Adolesc Psychiatry (2009) 1.01
Enhancing ADHD medication adherence: challenges and opportunities. Curr Psychiatry Rep (2013) 0.99
Single-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteers. J Child Adolesc Psychopharmacol (2014) 0.90
Long-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacy. BMJ Open (2013) 0.88
Extended-release medications for children and adolescents with attention-deficit hyperactivity disorder. Paediatr Child Health (2009) 0.83
Long-acting medications for the hyperkinetic disorders. A note on cost-effectiveness. Eur Child Adolesc Psychiatry (2007) 0.82
The NICE ADHD health technology assessment: a review and critique. Child Adolesc Psychiatry Ment Health (2008) 0.81
A review of long-acting medications for ADHD in Canada. J Can Acad Child Adolesc Psychiatry (2009) 0.80
What contributes to patient and parent satisfaction with medication in the treatment of children with ADHD? A report on the development of a new rating scale. Eur Child Adolesc Psychiatry (2011) 0.80
Switching from methylphenidate immediate release to MPH-SODAS in attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry (2008) 0.79
Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study. J Child Adolesc Psychopharmacol (2010) 0.79
Remission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate. J Child Adolesc Psychopharmacol (2012) 0.79
A preliminary analysis of the phenomenology of skin-picking in Prader-Willi syndrome. Child Psychiatry Hum Dev (2010) 0.78
Efficacy and safety of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder and recent methylphenidate use. Adv Ther (2013) 0.78
Switching from Methylphenidate-Immediate Release (MPH-IR) to Methylphenidate-OROS (OROS-MPH): A Multi-center, Open-label Study in Korea. Clin Psychopharmacol Neurosci (2011) 0.77
The Amygdala's Neurochemical Ratios after 12 Weeks Administration of 20 mg Long-acting Methylphenidate in Children with Attention Deficit and Hyperactivity Disorder: A Pilot Study Using (1)H Magnetic Resonance Spectroscopy. Clin Psychopharmacol Neurosci (2014) 0.76
Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study. Neuropsychiatr Dis Treat (2013) 0.76
Comparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysis. Med J Islam Repub Iran (2016) 0.75
Effectiveness and safety of methylphenidate and atomoxetine for attention deficit hyperactivity disorder: a systematic review. Transl Pediatr (2012) 0.75
A comparison of methylphenidate formulations in the treatment of ADHD. Can J Clin Pharmacol (2006) 0.75
An Open-label, Self-control, Prospective Study on Cognitive Function, Academic Performance, and Tolerability of Osmotic-release Oral System Methylphenidate in Children with Attention-deficit Hyperactivity Disorder. Chin Med J (Engl) (2015) 0.75
Changes in behavior as side effects in methylphenidate treatment: review of the literature. Neuropsychiatr Dis Treat (2016) 0.75
The role of galenic innovation in improving treatment compliance and persistence: three case studies. Clinicoecon Outcomes Res (2011) 0.75
Effects of maternal symptom ratings and other clinical features on short-term treatment response to OROS methylphenidate in children and adolescents with ADHD in a naturalistic clinical setting. Klinik Psikofarmakol Bulteni (2016) 0.75
Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison. Eur Child Adolesc Psychiatry (2017) 0.75
Effect of Ferritin on Short-Term Treatment Response in Attention Deficit Hyperactivity Disorder. Klinik Psikofarmakol Bulteni (2016) 0.75
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry (2006) 11.25
Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry (2006) 10.19
Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). J Am Acad Child Adolesc Psychiatry (2006) 10.00
Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry (2006) 9.85
The National Children's Study: a 21-year prospective study of 100,000 American children. Pediatrics (2006) 3.16
Previously suicidal adolescents: predictors of six-month outcome. J Can Acad Child Adolesc Psychiatry (2008) 2.98
Transdermal delivery of insulin using microneedles in vivo. Pharm Res (2004) 2.07
Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Sci Health A Tox Hazard Subst Environ Eng (2006) 1.89
Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2013) 1.67
The services for children and adolescents-parent interview: development and performance characteristics. J Am Acad Child Adolesc Psychiatry (2004) 1.64
A twin study of attention-deficit/hyperactivity disorder dimensions rated by the strengths and weaknesses of ADHD-symptoms and normal-behavior (SWAN) scale. Biol Psychiatry (2006) 1.61
Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry (2008) 1.61
Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway. J Biol Chem (2003) 1.43
A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers. Mol Ther (2010) 1.38
Systematic review of national and international guidelines on attention-deficit hyperactivity disorder. J Psychopharmacol (2011) 1.37
Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry (2005) 1.26
Ice lithography for nanodevices. Nano Lett (2010) 1.26
The effect of methylphenidate on three forms of response inhibition in boys with AD/HD. J Abnorm Child Psychol (2003) 1.25
Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling. Circ Res (2012) 1.20
Remote monitoring after recent hospital discharge in patients with heart failure: a systematic review and network meta-analysis. Heart (2013) 1.09
ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry (2003) 1.09
Dopamine receptor D4 (DRD4) gene in Han Chinese children with attention-deficit/hyperactivity disorder (ADHD): increased prevalence of the 2-repeat allele. Am J Med Genet B Neuropsychiatr Genet (2005) 1.08
Inattention, working memory, and academic achievement in adolescents referred for attention deficit/hyperactivity disorder (ADHD). Child Neuropsychol (2011) 1.07
Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study. J Clin Psychiatry (2007) 1.04
Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in the Multimodal Treatment Study of Children With ADHD: developmental cascades and vicious cycles. Dev Psychopathol (2010) 1.00
Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder. Paediatr Drugs (2003) 0.99
Adverse reactions to methylphenidate treatment for attention-deficit/hyperactivity disorder: structure and associations with clinical characteristics and symptom control. J Child Adolesc Psychopharmacol (2009) 0.99
Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2007) 0.97
Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol (2006) 0.96
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Ann Clin Psychiatry (2012) 0.95
ADHD treatments, sleep, and sleep problems: complex associations. Neurotherapeutics (2012) 0.95
Interaction of hormone-sensitive lipase with steroidogenic acute regulatory protein: facilitation of cholesterol transfer in adrenal. J Biol Chem (2003) 0.94
Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2004) 0.93
Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trials. Am J Geriatr Psychiatry (2005) 0.92
Pseudoangiomatous stromal hyperplasia of the breast in pediatric patients: an underrecognized entity. Pediatr Dev Pathol (2010) 0.92
PGE2 differentially regulates monocyte-derived dendritic cell cytokine responses depending on receptor usage (EP2/EP4). Mol Immunol (2013) 0.88
Heart-type fatty acid binding protein as an early marker for myocardial infarction: systematic review and meta-analysis. Emerg Med J (2012) 0.88
Chronic exercise modifies age-related telomere dynamics in a tissue-specific fashion. J Gerontol A Biol Sci Med Sci (2012) 0.88
Time course and predictors of health-related quality of life improvement and medication satisfaction in children diagnosed with attention-deficit/hyperactivity disorder treated with the methylphenidate transdermal system. J Child Adolesc Psychopharmacol (2010) 0.87
Prostamide F(2) α receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibition. Br J Pharmacol (2014) 0.86
Femtosecond plasma mediated laser ablation has advantages over mechanical osteotomy of cranial bone. Lasers Surg Med (2012) 0.86
Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults. Curr Psychiatry Rep (2007) 0.86
Subvisible retinal laser therapy: titration algorithm and tissue response. Retina (2014) 0.86
Future research directions in sleep and ADHD: report of a consensus working group. J Atten Disord (2012) 0.85
Describing use of nursing interventions for three groups of patients. J Nurs Scholarsh (2005) 0.85
Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr (2002) 0.85
A novel method for simultaneous Enterococcus species identification/typing and van genotyping by high resolution melt analysis. J Microbiol Methods (2012) 0.84
Measuring methylphenidate response in attention-deficit/hyperactvity disorder: how are laboratory classroom-based measures related to parent ratings? J Child Adolesc Psychopharmacol (2009) 0.83
Molecular and ultrastructural confirmation of classification of ATCC 35122 as a strain of Pirellula staleyi. Int J Syst Evol Microbiol (2002) 0.83
Vasoconstriction by electrical stimulation: new approach to control of non-compressible hemorrhage. Sci Rep (2013) 0.83
Atherogenic diet causes lethal ileo-ceco-colitis in cyclooxygenase-2 deficient mice. Prostaglandins Other Lipid Mediat (2007) 0.83
The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities. CNS Spectr (2007) 0.82
Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment: impact on parental practices. J Am Acad Child Adolesc Psychiatry (2004) 0.81
Prospective clinical evaluation of 1440-nm laser delivered by microarray for treatment of photoaging and scars. J Drugs Dermatol (2006) 0.81
HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system. Curr Med Res Opin (2009) 0.81
Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modelling of alternative service designs. BMJ Open (2013) 0.80
Maintenance study for adolescent depression. J Child Adolesc Psychopharmacol (2008) 0.80
Does childhood positive self-perceptual bias mediate adolescent risky behavior in youth from the MTA study? J Consult Clin Psychol (2013) 0.79
Do formulation switches exacerbate existing medical illness? Results of an open-label transition to orally disintegrating risperidone tablets. Hum Psychopharmacol (2007) 0.79
DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics. Pharmgenomics Pers Med (2010) 0.79
Exercise alters mRNA expression of telomere-repeat binding factor 1 in skeletal muscle via p38 MAPK. J Appl Physiol (1985) (2012) 0.79
Operator independent focused high frequency ISM band for fat reduction: porcine model. Lasers Surg Med (2013) 0.78
Treatment of catatonia with electroconvulsive therapy in adolescents. J Child Adolesc Psychopharmacol (2012) 0.78
Time-of-day effects in arousal: disrupted diurnal cortisol profiles in children with ADHD. J Child Psychol Psychiatry (2012) 0.78
Inferior retinal light exposure is more effective than superior retinal exposure in suppressing melatonin in humans. J Biol Rhythms (2003) 0.77
Kawasaki disease: four case reports of cardiopathy with an institutional and literature review. Pediatr Dev Pathol (2007) 0.77
Exploring the associations between microRNA expression profiles and environmental pollutants in human placenta from the National Children's Study (NCS). Epigenetics (2015) 0.77
Pharmacological management of a youth with ADHD and a seizure disorder. J Am Acad Child Adolesc Psychiatry (2006) 0.77
Research psychologists' roles in the genetic revolution. Am Psychol (2003) 0.76
Reduced mortality with noninvasive hemodynamic monitoring of shock. J Crit Care (2010) 0.76
Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials. Int Clin Psychopharmacol (2005) 0.76
Nature of the slow relaxation of smooth muscle induced by a EP2 receptor agonist with a non-prostanoid structure. Prostaglandins Leukot Essent Fatty Acids (2013) 0.75
Re: New models for large prospective studies: is there a better way? Am J Epidemiol (2013) 0.75
Stunted Growth. Proceedings of the 23rd Aschauer Soiree, Held at Aschauhof, Germany, November 7th 2015. Pediatr Endocrinol Rev (2016) 0.75
HRM confirmation of Neisseria gonorrhoeae in clinical specimens by G→A (position 857) mutation detection in the 16S rRNA gene before sequencing and after porA confirmation. J Microbiol Methods (2012) 0.75
Two-treatment protocol for skin laxity using 90-Watt dynamic monopolar radiofrequency device with real-time impedance intelligence monitoring. J Drugs Dermatol (2014) 0.75
When patients do not have a proxy: a procedure for medical decision making when there is no one to speak for the patient. J Clin Ethics (2006) 0.75
The effects of instructions on mothers' ratings of child attention-deficit/hyperactivity disorder symptoms. J Abnorm Child Psychol (2011) 0.75
Regulation of hormone-sensitive lipase in islets. Diabetes Res Clin Pract (2006) 0.75
Unusual presentation of ovarian cellular fibroma coexisting with nodular sclerosing Hodgkin's disease: a case report and review of the literature. J Pediatr Surg (2008) 0.75
The safety of co-administered continuous epidural analgesia and low-molecular-weight heparin after major orthopedic surgery: assessment of a standardized patient management protocol. Thromb Haemost (2006) 0.75